InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Why Myriad case could jeopardise patents on genes

Alli Pyrah, New York


Thousands of granted US patents relating to human genes may be in danger as a result of the Supreme Court’s decision to review the Myriad case

The case, The Association for Molecular Pathology v Myriad Genetics, involves Myriad’s patent claims to the isolated DNA of the BRCA 1 and BRCA 2 genes, which can help doctors assess a woman’s risk of breast cancer and ovarian cancer....


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null null null

null null null


November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing



Most read articles

Supplements